首页 | 本学科首页   官方微博 | 高级检索  
检索        

倍他乐克治疗慢性充血性心力衰竭疗效观察
引用本文:陈叶柔,朱广义.倍他乐克治疗慢性充血性心力衰竭疗效观察[J].河南科技大学学报(医学版),2004,22(1):15-16.
作者姓名:陈叶柔  朱广义
作者单位:1. 洛阳市商业职工医院内科,河南洛阳,471000
2. 解放军信息工程学院门诊部,河南郑州,450002
摘    要:目的 观察倍他乐克治疗慢性充血性心力衰竭疗效。方法  66例慢性心衰患者随机分为两组 ,治疗组在对照组常规治疗的基础上加用倍他乐克治疗 ,6个月后 ,观察治疗前后临床症状、心率、血压、心功能分级 ,评判疗效。结果 治疗组在减慢心率、改善心功能方面均优于对照组 ,总有效率分别为 91 .2 %和 71 .8% ,两组比较差异显著P <0 .0 1。结论 倍他乐克治疗慢性充血性心力衰竭安全有效

关 键 词:倍他乐克  治疗  慢性充血性心力衰竭  心功能  β受体阻滞剂
文章编号:1672-688X(2004)01-0015-02
修稿时间:2003年12月25

Clinical Efficacy of Betaloc for Treatment of Chronic Heart Failure
CHEN Ye-rou,ZHU Guang-yi.Clinical Efficacy of Betaloc for Treatment of Chronic Heart Failure[J].Journal of Henan University of Science & Technology:Medical Science,2004,22(1):15-16.
Authors:CHEN Ye-rou  ZHU Guang-yi
Abstract:Objective To study the effect of betaloc in the treatment of chronic heart failure. Methods 66 patients were divided into two groups: treatment group and control group. The patients in treatment group were treated with common therapy combining with betaloc for six months. Before and after treatment, clinical symptoms,heart rate, blood pressure, NYHA class were observed and evaluated. Results Comparing treatment group with control group, the effect in decreasing heart rate and improving NYHA was better. The effective rate was 91.2% and 71.8% respectively. The effective rate showed apparent difference between two groups (P<0.01). Conclusion Betaloc is effective and safe in CHF patients.
Keywords:
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号